Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms and Therapeutic Targets of Botanicals Derived from Asteraceae Plant Species.

Pharmaceutics·2026
Same author

Tin(II) Dithiocarbamate-Derived SnS Nanoparticles for High-Performance Quantum Dot-Sensitized Solar Cells.

Nanomaterials (Basel, Switzerland)·2026
Same author

Structural Modification of Selected Essential Oil Components for Potential Anticancer Applications: A Review.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Recent Developments on Coumarin Hybrids as Antimicrobial Agents.

Antibiotics (Basel, Switzerland)·2025
Same author

Predictive removal of nickel (II) from wastewater onto cellulose nanocrystal nanocomposite using deep machine learning.

Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering·2025
Same author

Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery.

Pharmaceutics·2025

Related Experiment Video

Updated: Jun 13, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Recent Developments in Ferulic Acid- and Caffeic Acid-Based Hybrids with Potential Anticancer Properties.

Sijongesonke Peter1, Linda Lunga Sibali2, Vuyolwethu Khwaza1

  • 1Department of Chemical and Earth Sciences, Chemistry Discipline, Faculty of Science and Agriculture, University of Fort Hare, Alice 5700, South Africa.

Molecules (Basel, Switzerland)
|June 12, 2026
PubMed
Summary

New hybrid compounds combining ferulic acid and caffeic acid show significant potential as novel anticancer agents. These drug candidates aim to overcome limitations of current chemotherapy by enhancing efficacy and reducing side effects.

Keywords:
anticancercaffeic aciddrug resistanceferulic acidhybridizationhydrocinnamic acidspharmacophores

More Related Videos

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Related Experiment Videos

Last Updated: Jun 13, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Chemotherapeutic drug resistance, toxicity, and poor bioavailability limit current cancer treatments.
  • Phenolic acids like ferulic and caffeic acids possess diverse biological activities, including anticancer properties.
  • Drug hybridization and repurposing offer efficient strategies to develop novel therapeutic agents.

Purpose of the Study:

  • To review recent in vitro and in silico studies (2022-2025) on hybrid compounds derived from ferulic and caffeic acids.
  • To analyze structure-activity relationships and synthetic modifications enhancing anticancer potential.
  • To highlight the promise of these hybrid compounds as next-generation anticancer therapeutics.

Main Methods:

  • Literature review of in vitro and in silico studies on ferulic and caffeic acid hybrids.
  • Analysis of structure-activity relationships (SAR) and synthetic strategies.
  • Evaluation of cytotoxic and antiproliferative effects against cancer cell lines.

Main Results:

  • Hybrid compounds of ferulic and caffeic acids demonstrate significant cytotoxic and antiproliferative activities.
  • Specific structural modifications and hybridization approaches enhance anticancer efficacy.
  • Positive structure-activity relationship trends were identified for improved biological outcomes.

Conclusions:

  • Ferulic and caffeic acid hybrid scaffolds hold substantial promise for developing novel, multifunctional anticancer agents.
  • These hybrids offer a potential solution to overcome limitations of existing chemotherapeutics.
  • Further research into these compounds could lead to advanced cancer therapies.